Beijing Introduces White List System for Biomedical R&D Item Imports
Beijing has announced the introduction of a ‘white list’ system to facilitate the import of...
Ocumension Therapeutics’ OT-401 Approved for Chronic Non-Infectious Uveitis in China
China-based Ocumension Therapeutics (HKG: 1477) has received approval from the National Medical Products Administration (NMPA)...
AstraZeneca Expands in China with Qingdao Partnership and Manufacturing Base
UK-based pharmaceutical giant AstraZeneca (NASDAQ: AZN) is significantly expanding its presence in China through a...
CStone Pharmaceuticals’ Ayvakit Included in Taiwan’s National Health Insurance
China-based CStone Pharmaceuticals (HKG: 2616) announced that its Ayvakit (avapritinib), a tyrosine kinase inhibitor for...
Eureka Biotechnology Secures RMB 100 Million for Cell and Gene Therapy Solutions
Shenzhen-based Eureka Biotechnology, a company specializing in comprehensive solutions for the cell and gene therapy...
Therorna Secures Over RMB 280 Million in Series A Round to Accelerate circRNA Tech Development
China-based Therorna Inc., a biotech company specializing in cutting-edge circular RNA (circRNA) technology for next-generation...
Qingdao HuaRen Pharmaceutical Gains CE Marks for Monkeypox and COVID-19 Detection Kits
China-based Qingdao HuaRen Pharmaceutical Co., Ltd (SHE: 300110) has announced receiving CE marks in the...
SSY Group’s Blonanserin and Paracetamol Approved by China’s NMPA
China-based SSY Group Limited (HKG: 2005) has announced receiving market approvals from the National Medical...
Shanghai ShineYo Medical Device Secures RMB 100 Million in Series A Round
Shanghai ShineYo Medical Device Co., Ltd, a company specializing in electrophysiology and peripheral intervention, has...
Boehringer Ingelheim Venture Fund and Hong Kong Science Park Launch Co-Incubation Plan
Germany-based pharmaceutical giant Boehringer Ingelheim’s venture fund (BIVF) and China-based Hong Kong Science & Technology...
Innovent Biologics’ Tyvyt Approved for First-Line Esophageal Squamous Cell Carcinoma
The National Medical Products Administration (NMPA) website indicates that China-based Innovent Biologics, Inc. (HKG: 1801)...
China’s Seventh National Volume-based Procurement Round Kicks Off with Revised Rules
China’s health authorities have resumed the seventh national volume-based procurement (VBP) round after a pandemic-related...
Shenzhen AXBio Closes USD 100 Million Series B Round for Sequencing Tech Expansion
Shenzhen-based fourth-generation sequencing company Anxuyuan Biotechnology (shenzhen) Company Limited (AXBio) has reportedly secured close to...
Boston Scientific Launches Expect Airway Ultrasound Needle in China for Lung Cancer Diagnosis
US-based Boston Scientific Corporation (NYSE: BSX) has announced the official market launch of its Expect...
Iomics Biosciences Secures RMB 100 Million for Proteomics and Spatialomics Expansion
Beijing-based Iomics Biosciences Co., Ltd, a developer of gene sequencing and diagnostic equipment, has reportedly...
InnoCare and Keymed Biosciences’ CCR8-Targeted mAb CM369 Accepted by NMPA
China-based InnoCare (HKG: 9969) and Keymed Biosciences Inc. (HKG: 2162) announced that an Investigational New...
CDE Releases 58th and 59th Batches of Chemical Generic Reference Preparations
The Center for Drug Evaluation (CDE) has released the 58th and 59th batches of chemical...
Shenzhen’s LWPOCT Secures RMB 100 Million in Series A Round for CDMO Expansion
Shenzhen-based medical devices and reagents manufacturer Shenzhen Living Water POCT Co., LTd (LWPOCT) has reportedly...
Henlius Biotech Begins Global Phase III Trial for Denosumab Biosimilar HLX14
China-based Shanghai Henlius Biotech Inc. (HKG: 2696) has announced the first patient dosing in a...
Cellular Biomedicine Group’s C-CAR039 Receives NMPA Approval for B-Cell NHL Study
China-based Cellular Biomedicine Group Inc. (CBMG), a private company following a merger deal in February...